×
About 3,891 results

ALLMedicine™ Brugada Syndrome Center

Research & Reviews  1,923 results

The puzzle of genetics in Brugada syndrome: a disease with a high risk of sudden cardia...
https://doi.org/10.21037/apm-20-1510
Annals of Palliative Medicine; Chen CJ, Chuang EY

Sep 14th, 2020 - The puzzle of genetics in Brugada syndrome: a disease with a high risk of sudden cardiac death in young people.|2020|Chen CJ,Chuang EY,|

Enhancing rare variant interpretation in inherited arrhythmias through quantitative ana...
https://doi.org/10.1038/s41436-020-00946-5
Genetics in Medicine : Official Journal of the American College of Medical Genetics; Walsh R, Lahrouchi N et. al.

Sep 7th, 2020 - Stringent variant interpretation guidelines can lead to high rates of variants of uncertain significance (VUS) for genetically heterogeneous disease like long QT syndrome (LQTS) and Brugada syndrome (BrS). Quantitative and disease-specific customi...

Low rate of life-threatening events and limitations in predicting invasive and non-inva...
https://doi.org/10.1111/jce.14732
Journal of Cardiovascular Electrophysiology; Sacilotto L, Scanavacca MI et. al.

Sep 1st, 2020 - Brugada syndrome (BrS) has diagnostic challenges and controversial risk assessment. We aimed to investigate invasive and non-invasive parameters in symptomatic and asymptomatic patients from a Brazilian cohort of type-1 BrS. Patients with spontane...

Ajmaline Testing and the Brugada Syndrome.
https://doi.org/10.1016/j.amjcard.2020.08.024
The American Journal of Cardiology; Rizzo A, Borio G et. al.

Aug 26th, 2020 - Brugada syndrome (BrS) diagnosis requires the presence of a typical type 1 ECG pattern. Owing to the spontaneous ECG variability, the real BrS prevalence in the general population remains unclear. The aim of the present study was to evaluate the p...

Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients w...
https://doi.org/10.1007/s00380-020-01683-0
Heart and Vessels; Shinohara T, Abe I et. al.

Aug 23rd, 2020 - Implantable cardioverter-defibrillators (ICDs) are the main therapy to prevent sudden cardiac death in patients with Brugada syndrome (BrS). The subcutaneous ICD (S-ICD) can eliminate lead-associated complications compared with transvenous ICD (TV...

see more →

Guidelines  1 results

Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventric...
http://circ.ahajournals.org/content/early/2017/10/30/CIR.0000000000000550
Fred M. Kusumoto

Jul 31st, 2018 - Our analysis has 2 objectives. First, to evaluate whether ventricular arrhythmias (VAs) induced with programmed electrostimulation in asymptomatic patients with Brugada syndrome identify a higher risk group that may require additional testing or t.

see more →

Clinicaltrials.gov  1,949 results

The puzzle of genetics in Brugada syndrome: a disease with a high risk of sudden cardia...
https://doi.org/10.21037/apm-20-1510
Annals of Palliative Medicine; Chen CJ, Chuang EY

Sep 14th, 2020 - The puzzle of genetics in Brugada syndrome: a disease with a high risk of sudden cardiac death in young people.|2020|Chen CJ,Chuang EY,|

Enhancing rare variant interpretation in inherited arrhythmias through quantitative ana...
https://doi.org/10.1038/s41436-020-00946-5
Genetics in Medicine : Official Journal of the American College of Medical Genetics; Walsh R, Lahrouchi N et. al.

Sep 7th, 2020 - Stringent variant interpretation guidelines can lead to high rates of variants of uncertain significance (VUS) for genetically heterogeneous disease like long QT syndrome (LQTS) and Brugada syndrome (BrS). Quantitative and disease-specific customi...

Low rate of life-threatening events and limitations in predicting invasive and non-inva...
https://doi.org/10.1111/jce.14732
Journal of Cardiovascular Electrophysiology; Sacilotto L, Scanavacca MI et. al.

Sep 1st, 2020 - Brugada syndrome (BrS) has diagnostic challenges and controversial risk assessment. We aimed to investigate invasive and non-invasive parameters in symptomatic and asymptomatic patients from a Brazilian cohort of type-1 BrS. Patients with spontane...

Ajmaline Testing and the Brugada Syndrome.
https://doi.org/10.1016/j.amjcard.2020.08.024
The American Journal of Cardiology; Rizzo A, Borio G et. al.

Aug 26th, 2020 - Brugada syndrome (BrS) diagnosis requires the presence of a typical type 1 ECG pattern. Owing to the spontaneous ECG variability, the real BrS prevalence in the general population remains unclear. The aim of the present study was to evaluate the p...

Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients w...
https://doi.org/10.1007/s00380-020-01683-0
Heart and Vessels; Shinohara T, Abe I et. al.

Aug 23rd, 2020 - Implantable cardioverter-defibrillators (ICDs) are the main therapy to prevent sudden cardiac death in patients with Brugada syndrome (BrS). The subcutaneous ICD (S-ICD) can eliminate lead-associated complications compared with transvenous ICD (TV...

see more →

News  11 results

Brugada Genes Debunked; T2D Drug Excuses; Paradise Pivotal Trial
https://www.medpagetoday.com/cardiology/prevention/73911

Jul 8th, 2018 - A study reevaluating genes reported to be associated with Brugada syndrome challenged the validity of all but one. (Circulation) The American College of Cardiology renamed its ACTION Registry under the National Cardiovascular Data Registry umbrell...

Study: ICD Therapy Effective in Brugada Syndrome Long-Term
https://www.medpagetoday.com/cardiology/arrhythmias/68461

Oct 10th, 2017 - Action Points Long-term follow-up of Brugada syndrome patients confirmed the efficacy of implanted cardioverter-defibrillator (ICD) devices but also substantial adverse event risk. The predictors of appropriate therapy were a type 1 electrocardiog...

Absorb Stent Off Market; 9/11 Dust Lipid Effects; New AUC in Valvular Imaging
https://www.medpagetoday.com/cardiology/prevention/67813

Sep 11th, 2017 - The Absorb bioresorbable stent will come rapidly off the market worldwide due to poor sales, Abbott announced, although the firm may return with a second-generation device. MedPage Today has the full story here. Kids' exposure to chemical-laden du...

Brugada Syndrome: Subcutanous ICDs Linked to Misfires
https://www.medpagetoday.com/cardiology/arrhythmias/59505

Aug 3rd, 2016 - Patients with Brugada syndrome are at risk of inappropriate shocks from subcutaneous implantable cardioverter-defibrillator (sICD) during changes in their electrocardiogram (ECG) pattern, investigators found. Morphology analysis failed in 24% of p...

Brugada Syndrome: 'New Era' of Milder Disease at Diagnosis
https://www.medpagetoday.com/cardiology/arrhythmias/59484

Aug 2nd, 2016 - Action Points Note that this registry study of patients with Brugada syndrome found that the disease has become milder over the years, likely due to increased rates of identification of more mild disease. This has led to some questioning the use o...

see more →

Patient Education  7 results see all →